Status of hyperthermia in the treatment of advanced liver cancer.
The vast majority of patients with malignant liver tumors have inoperable disease. These patients must rely on chemotherapy, radiotherapy, and various locoregional treatments. Although these treatments have demonstrated encouraging response rates, symptom palliation and occasional down staging of tumors, their impact on survival is minor. As a result there has been renewed interest in hyperthermia as a treatment option. This study reviews the current modalities of hyperthermia in terms of clinical results, side effects, limitations, and therapeutic standing.
Moroz
P
P
Centre for Applied Cancer Studies, University of Western Australia, Nedlands, 6000 Perth, Western Australia. pmoroz@cyllene.uwa.edu.au
Jones
S K
SK
Gray
B N
BN
D006528:Carcinoma, Hepatocellular / Q000601:surgery / Q000628:therapy; D017115:Catheter Ablation / Q000009:adverse effects; D010478:Chemotherapy, Cancer, Regional Perfusion; D015179:Colorectal Neoplasms / Q000556:secondary; D004621:Embolization, Therapeutic; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D017075:Laser Coagulation / Q000009:adverse effects; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008872:Microwaves / Q000627:therapeutic use; D014464:Ultrasonic Therapy